Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 11/20 | 0.50 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.49 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3227907 | 1.00 | CNR2 (0.50) | CNR2CHRM3HRH3 | |
| SCHEMBL283563 | 0.91 | CNR2 (0.59) | CNR2 | |
| SCHEMBL283562 | 0.91 | CNR2 (0.59) | CNR2 | |
| SCHEMBL2171809 | 0.87 | CHRM3 (0.51) | CNR2CHRM3HRH3 | |
| SCHEMBL283145 | 0.81 | CNR2 (0.59) | CNR2 | |
| SCHEMBL283589 | 0.81 | CNR2 (0.59) | CNR2 | |
| SCHEMBL283588 | 0.81 | CNR2 (0.59) | CNR2 | |
| SCHEMBL283146 | 0.81 | CNR2 (0.59) | CNR2 | |
| SCHEMBL8219053 | 0.80 | CNR2 (0.51) | CNR2 | |
| SCHEMBL11457893 | 0.79 | CHRNB4 (0.54) | CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100069349-A1 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 2010-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069349-A1 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS | CNR1, CNR2, NPY1R | CNR2 2/4885CHRM3 173/4885HRH3 176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.